10-K Filing

NOVO INTEGRATED SCIENCES, INC. CIK: 1138978 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001493152-19-018107`
Period End Date	20190831
Filing Date	20191120
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	nvos-20190831.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 81 Income Statement 46 Cash Flow Statement 65 Stockholders Equity 21

Balance Sheet 81 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.08M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$675.71K	USD	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.46M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.34M	USD	Point-in-time
Other receivables, current portion	`OtherReceivablesNetCurrent`	$300.99K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivables, current portion	`OtherReceivablesNetCurrent`	$393.82K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	499.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	499.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$161.84K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$250.40K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	223.69M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	207.88M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.10M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.57M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	223.69M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$400.32K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	207.88M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$410.19K	USD	Point-in-time
Intangible assets	`FiniteLivedIntangibleAssetsNet`	$22.36M	USD	Point-in-time
Intangible assets	`FiniteLivedIntangibleAssetsNet`	-	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$3.00M	USD	Point-in-time
Other receivables, net of current portion	`LongTermInvestmentsAndReceivablesNet`	$57.35K	USD	Point-in-time
Other receivables, net of current portion	`LongTermInvestmentsAndReceivablesNet`	$1.06M	USD	Point-in-time
Acquisition deposits	`DepositsAssetsNoncurrent`	$716.69K	USD	Point-in-time
Acquisition deposits	`DepositsAssetsNoncurrent`	$1.11M	USD	Point-in-time
Goodwill	`Goodwill`	$623.08K	USD	Point-in-time
Goodwill	`Goodwill`	$604.11K	USD	Point-in-time
Goodwill	`Goodwill`	$399.40K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$32.27M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$4.74M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.14M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.31M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$205.78K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$384.00K	USD	Point-in-time
Accrued interest (principally to related parties)	`InterestPayableCurrent`	$248.58K	USD	Point-in-time
Accrued interest (principally to related parties)	`InterestPayableCurrent`	$156.12K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$1.12M	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$920.08K	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	-	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$382.35K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$508.31K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.03M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.35M	USD	Point-in-time
Debentures, related parties	`SecuredLongTermDebt`	$1.22M	USD	Point-in-time
Debentures, related parties	`SecuredLongTermDebt`	$1.20M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$2.50M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$6.73M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$4.57M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at August 31, 2019 and 2018	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.001par value; 499,000,000 shares authorized; 223,691,507 and 207,881,743 shares issued and outstanding at August 31, 2019 and 2018	`CommonStockValue`	$223.69K	USD	Point-in-time
Common stock; $0.001par value; 499,000,000 shares authorized; 223,691,507 and 207,881,743 shares issued and outstanding at August 31, 2019 and 2018	`CommonStockValue`	$207.88K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$10.05M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$35.81M	USD	Point-in-time
Other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.14M	USD	Point-in-time
Other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.14M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.20M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.59M	USD	Point-in-time
Total Novo Integrated Sciences, Inc. stockholders' equity	`StockholdersEquity`	$25.58M	USD	Point-in-time
Total Novo Integrated Sciences, Inc. stockholders' equity	`StockholdersEquity`	$201.39K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-39.63K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-28.62K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$172.77K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.29M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.54M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$32.27M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$4.74M	USD	Point-in-time

Income Statement 46 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$9.42M	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$8.89M	USD	Annual
Cost of revenues	`CostOfRevenue`	$5.90M	USD	Annual
Cost of revenues	`CostOfRevenue`	$5.47M	USD	Annual
Gross profit	`GrossProfit`	$3.42M	USD	Annual
Gross profit	`GrossProfit`	$3.52M	USD	Annual
Selling expenses	`SellingExpense`	$109.30K	USD	Annual
Selling expenses	`SellingExpense`	$39.93K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$4.88M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$4.02M	USD	Annual
Write down of assets	`AssetImpairmentCharges`	$245.25K	USD	Annual
Write down of assets	`AssetImpairmentCharges`	-	USD	Annual
Total operating expenses	`OperatingExpenses`	$4.99M	USD	Annual
Total operating expenses	`OperatingExpenses`	$4.31M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-1.57M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-785.60K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$16.70K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$154.79K	USD	Annual
Interest expense	`OtherNonoperatingExpense`	$564.47K	USD	Annual
Interest expense	`OtherNonoperatingExpense`	$222.16K	USD	Annual
Other income	`OtherNonoperatingIncome`	$72.08K	USD	Annual
Other income	`OtherNonoperatingIncome`	-	USD	Annual
Gain on settlement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain on settlement of debt	`GainsLossesOnExtinguishmentOfDebt`	$377.30K	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$382.02K	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-547.76K	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.12M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-403.58K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`ProfitLoss`	$-403.58K	USD	Annual
Net loss	`ProfitLoss`	$-2.12M	USD	Annual
Net loss attributed to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-11.60K	USD	Annual
Net loss attributed to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-9.18K	USD	Annual
Net loss attributed to Novo Integrated Sciences, Inc.	`NetIncomeLoss`	$-2.11M	USD	Annual
Net loss attributed to Novo Integrated Sciences, Inc.	`NetIncomeLoss`	$-391.98K	USD	Annual
Net loss	`ProfitLoss`	$-403.58K	USD	Annual
Net loss	`ProfitLoss`	$-2.12M	USD	Annual
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-101.03K	USD	Annual
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-896.00	USD	Annual
Comprehensive loss:	`ComprehensiveIncomeNetOfTax`	$-2.22M	USD	Annual
Comprehensive loss:	`ComprehensiveIncomeNetOfTax`	$-404.48K	USD	Annual
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	217.32M	shares	Annual
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	207.57M	shares	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	Annual

Cash Flow Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-403.58K	USD	Annual
Net loss	`ProfitLoss`	$-2.12M	USD	Annual
Depreciation	`Depreciation`	$73.45K	USD	Annual
Depreciation	`Depreciation`	$97.14K	USD	Annual
Fair value of vested stock options	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue`	$-1.27M	USD	Annual
Fair value of vested stock options	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue`	$-70.85K	USD	Annual
Expense associated with modified stock option terms	`ExpenseAssociatedWithModifiedStockOptionTerms`	-	USD	Annual
Expense associated with modified stock option terms	`ExpenseAssociatedWithModifiedStockOptionTerms`	$31.54K	USD	Annual
Operating lease expense	`OperatingLeaseExpense`	-	USD	Annual
Operating lease expense	`OperatingLeaseExpense`	$313.18K	USD	1 Quarter
Operating lease expense	`OperatingLeaseExpense`	$214.89K	USD	Annual
Gain on settlement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain on settlement of debt	`GainsLossesOnExtinguishmentOfDebt`	$377.30K	USD	Annual
Write down of assets	`AssetImpairmentCharges`	$245.25K	USD	Annual
Write down of assets	`AssetImpairmentCharges`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$151.25K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$263.15K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-23.24K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$91.10K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-331.87K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-140.09K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-172.31K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$58.33K	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$95.81K	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$316.23K	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-210.58K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-934.50K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-822.27K	USD	Annual
Purchase of furniture and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$178.63K	USD	Annual
Purchase of furniture and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$107.64K	USD	Annual
Payment for acquisition deposit	`PaymentsForOtherDeposits`	$377.30K	USD	Annual
Payment for acquisition deposit	`PaymentsForOtherDeposits`	-	USD	Annual
Cash paid for acquisition of assets	`PaymentsToAcquireProductiveAssets`	$132.06K	USD	Annual
Cash paid for acquisition of assets	`PaymentsToAcquireProductiveAssets`	-	USD	Annual
Amounts loaned for other receivables	`PaymentsForProceedsFromLoansReceivable`	$225.92K	USD	Annual
Amounts loaned for other receivables	`PaymentsForProceedsFromLoansReceivable`	$38.60K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-842.91K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-217.23K	USD	Annual
Repayments to related parties	`RepaymentsOfRelatedPartyDebt`	$20.14K	USD	Annual
Repayments to related parties	`RepaymentsOfRelatedPartyDebt`	$176.66K	USD	Annual
Proceeds from the sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$3.25M	USD	Annual
Proceeds from the sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$15.56K	USD	Annual
Payments on notes payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Payments on notes payable	`RepaymentsOfNotesPayable`	$7.00K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-11.57K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.07M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-57.56K	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-568.00	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.41M	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.22M	USD	Annual
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.08M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$675.71K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.90M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.08M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$675.71K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF YEAR	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.90M	USD	Point-in-time
Interest	`InterestPaidNet`	$129.46K	USD	Annual
Interest	`InterestPaidNet`	$240.37K	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Common stock issued for intangible assets	`CommonStockIssuedForIntangibleAssets`	$22.36M	USD	Annual
Common stock issued for intangible assets	`CommonStockIssuedForIntangibleAssets`	-	USD	Annual
Common stock issued for acquisition of assets	`CommonStockIssuedForAcquisitionOfAssets`	-	USD	Annual
Common stock issued for acquisition of assets	`CommonStockIssuedForAcquisitionOfAssets`	$95.55K	USD	Annual

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$172.77K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.29M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.54M	USD	Point-in-time
Common stock issued for cash	`StockIssuedDuringPeriodValueNewIssues`	$15.56K	USD	Annual
Common stock issued for cash	`StockIssuedDuringPeriodValueNewIssues`	$3.25M	USD	Annual
Common stock issued for acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$233.16K	USD	Annual
Common stock issued for acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$95.55K	USD	Annual
Common stock issued for conversion of debt	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$5.12M	USD	Annual
Cancellation of common stock previously issued	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	Annual
Fair value of vested stock options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$1.27M	USD	Annual
Fair value of vested stock options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$70.85K	USD	Annual
Fair value of modification of stock option terms	`FairValueOfModificationOfStockOptionTerms`	$31.54K	USD	Annual
Foreign currency translation loss	`OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest`	$-99.93K	USD	Annual
Foreign currency translation loss	`OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest`	$-312.00	USD	Annual
Common stock issued for interest in joint venture	`StockIssuedDuringPeriodValueOther`	$21.60M	USD	Annual
Common stock issued for software license	`StockIssuedDuringPeriodValueForSoftwareLicense`	$758.57K	USD	Annual
Net loss	`ProfitLoss`	$-403.58K	USD	Annual
Net loss	`ProfitLoss`	$-2.12M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$172.77K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.29M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.54M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.